199 related articles for article (PubMed ID: 27743861)
21. Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.
Horowitz NS; Hua J; Powell MA; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2007 Nov; 107(2):344-9. PubMed ID: 17720233
[TBL] [Abstract][Full Text] [Related]
22. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
Xiao ZL; Biancani P; Carey MC; Behar J
Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
[TBL] [Abstract][Full Text] [Related]
23. Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy.
Perez MJ; Castaño B; Jimenez S; Serrano MA; Gonzalez-Buitrago JM; Marin JJ
Toxicol Appl Pharmacol; 2008 Oct; 232(2):327-36. PubMed ID: 18706437
[TBL] [Abstract][Full Text] [Related]
24. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis.
Rolo AP; Palmeira CM; Holy JM; Wallace KB
Toxicol Sci; 2004 May; 79(1):196-204. PubMed ID: 14976352
[TBL] [Abstract][Full Text] [Related]
25. Effects of chenodeoxy- and ursodeoxycholic acid on absorption, secretion and permeability in rat colon and small intestine.
Caspary WF; Meyne K
Digestion; 1980; 20(3):168-74. PubMed ID: 7390046
[TBL] [Abstract][Full Text] [Related]
26. Effect of chenodeoxycholic acid on the alterations of biliary lipid secretion induced by ethynylestradiol in the rat.
Bonazzi P; Novelli G; Galeazzi R
Br J Exp Pathol; 1986 Jun; 67(3):341-8. PubMed ID: 3718840
[TBL] [Abstract][Full Text] [Related]
27. [The influence of chenodeoxycholic acid and ursodeoxycholic acid on the hepatic structure of the rat (author's transl)].
Leuschner U; Schneider M; Korte L
Z Gastroenterol; 1979 Apr; 17(4):244-55. PubMed ID: 433375
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture.
Martinez-Diez MC; Serrano MA; Monte MJ; Marin JJ
Biochim Biophys Acta; 2000 Feb; 1500(2):153-60. PubMed ID: 10657584
[TBL] [Abstract][Full Text] [Related]
29. Effects of bile acids on iodide uptake and deoxyribonucleic acid synthesis in porcine thyroid cells in primary culture.
Kanri R; Takiyama Y; Makino I
Thyroid; 1996 Oct; 6(5):467-74. PubMed ID: 8936674
[TBL] [Abstract][Full Text] [Related]
30. Bile acids stimulate PKCalpha autophosphorylation and activation: role in the attenuation of prostaglandin E1-induced cAMP production in human dermal fibroblasts.
Le M; Krilov L; Meng J; Chapin-Kennedy K; Ceryak S; Bouscarel B
Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G275-87. PubMed ID: 16710050
[TBL] [Abstract][Full Text] [Related]
31. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat.
Crocenzi FA; D'Andrea V; Catania VA; Luquita MG; Pellegrino JM; Ochoa JE; Mottino AD; Sánchez Pozzi EJ
Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489
[TBL] [Abstract][Full Text] [Related]
32. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
[TBL] [Abstract][Full Text] [Related]
33. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
34. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
35. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
[TBL] [Abstract][Full Text] [Related]
36. Mitigation of intrahepatic cholestasis induced by 17α-ethinylestradiol via nanoformulation of Silybum marianum L.
Salem MB; Mohammed DM; Hammam OA; Elzallat M
BMC Complement Med Ther; 2024 Jan; 24(1):51. PubMed ID: 38263002
[TBL] [Abstract][Full Text] [Related]
37. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets.
Crocenzi FA; Sánchez Pozzi EJ; Pellegrino JM; Favre CO; Rodríguez Garay EA; Mottino AD; Coleman R; Roma MG
Hepatology; 2001 Aug; 34(2):329-39. PubMed ID: 11481618
[TBL] [Abstract][Full Text] [Related]
39. Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases.
Choi YH; Im EO; Suh H; Jin Y; Lee WH; Yoo YH; Kim KW; Kim ND
Int J Oncol; 2001 May; 18(5):979-84. PubMed ID: 11295044
[TBL] [Abstract][Full Text] [Related]
40. Interactions of combined bile acids on hepatocyte viability: cytoprotection or synergism.
Rolo AP; Palmeira CM; Wallace KB
Toxicol Lett; 2002 Feb; 126(3):197-203. PubMed ID: 11814708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
